Meet our experts at 2018 CHI BioProcessing Summit at booth #605.
Learn more about “Next Generation AAV Viral Vector Manufacturing: Proven Technologies with a Modern Twist” on Friday, August 17 at 12pm with Sandhya Buchanan, Director, Upstream Process Development
Current approaches to commercial-scale manufacture of viral vectors have been successful for many early phase trials and some late phase trials. Unique challenges/limitations arising for AAV manufacturing include quantities sufficient for patient needs and consumables for manufacturing. We discuss proven technologies blended with modern advancements to meet the needs of the advancing field of gene therapy.